About DendreonTherapeutic ApproachesPipelinePatient ResourcesInvestorsNewsroomCareers
Investors
Investors
Dendreon Corporation
3005 First Avenue
Seattle, WA 98121
ir@dendreon.com
(DNDN - Nasdaq)
Last Price:   $5.73    (- 0.21)
Industry:  Biotechnology & Drugs

Recent News Release
08/14/08 Dendreon Initiates Second of Two New Phase 2 Trials

Upcoming Calendar Events
09/04/08 Dendreon at BioCentury Publications Inc. NewsMakers in the Biotech Industry

Intraday Stock Quote

Office Max Stock Chart
3 Mo.   6 Mo.   1 Yr.

Dendreon Targeting Cancer, Transforming Lives

Governance
Stock Quote
Press Releases
Webcasts & Presentations
SEC Filings
Analyst Coverage
Annual Reports
Information Requests
Email Alerts
  

  Privacy Policy | Legal Notice
  © 2008 Dendreon Corporation. All Rights Reserved.
Home | Contact Dendreon | Site Map    Search